PhD, University of Pittsburgh Medical School
BS, Penn State University
HIV/AIDS, Aging
Alan L. Landay, PhD, is the professor of the Department of Immunity & Emerging Pathogens and principal investigator of the Rush Immunology Specialty Laboratory, or ISL, with 35 years experience in studies of HIV immunopathogenesis. He has worked with the AIDS Clinical Trials Group since its beginning and has directed the ISL since it began.
His studies on immunophenotyping and innate immunity in HIV disease have made significant contributions to this field. These early studies were carried out in a newly recognized population of hemophiliacs that were shown to develop AIDS. This work was extended with more recent publications using multi-parameter flow cytometry to define monocyte subsets and the critical role of monocytes and innate immune cell activation in HIV pathogenesis. These papers have contributed to a shift in thinking about HIV as an adaptive immune disease to one focused on innate cell driven inflammation linked to the development of immunosenescence.
2015 President, Association Medical School Microbiology and Immunology Chairs
2012 - 2013 Endowed Professor, F.C. Donders Chair, University of Utrecht, Netherlands
2012 Member, UNAIDS HIV and Aging Panel
2009 - 2011 Chair, Vaccine Study Section, NIAID/NIH
2011 Member, OAR HIV and Aging Panel
Co-Chair, Keystone HIV Pathogenesis Symposium
2004 - 2008 Member, Vaccine Study Section, NIAID/NIH
2003 Member, Bill and Melinda Gates Foundation Global Health Care Technologies
2003 Member, Scientific Advisory Board American Foundation of AIDS Research
2003 - 2016 Member, Etiology and Pathogenesis Planning Committee, NIH Office of AIDS Research
Member , Elizabeth Glazer Advisory Board Foundation
2001 - 2005 Member, Ontario HIV Treatment Network Scientific Review Committee
1997 Member Review Panel California AIDS Task Force, Chair Basic Science Panel